Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Evan Pisick"'
Autor:
Sarah J. Wu, MD, PhD, Justin J. Kim, Yeying Huang, BS, R. Taylor Durall, BS, Simone Becker, RN, Stephanie Canty, CNP, MSN, Stefania Molinaro, BS, Evan Pisick, MD, Geoffrey I. Shapiro, MD, PhD, Christopher A. French, MD, Jia Luo, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 1, Pp 100625- (2024)
We present the first known case of a patient with BRD2::NUTM1-driven NUT carcinoma. A 59-year-old woman presented with poorly differentiated squamous cell lung cancer metastatic to the pleura. Eventually, a positive NUT immunohistochemistry, NUT fluo
Externí odkaz:
https://doaj.org/article/b478d584323f4148b443ca10b9d2db17
Publikováno v:
The Scientific World Journal, Vol 4, Pp 589-604 (2004)
Lung cancer is a deadly disease with high mortality and morbidity. Most cases of lung cancer are due to non-small cell carcinoma, with 16% of cases being small cell carcinoma. The biology at a cellular level is of interest at many levels. Knowing cel
Externí odkaz:
https://doaj.org/article/7e184039e6a747909c08f5d59c44731c
Autor:
Eddy S. Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K. Mangat, Evan Pisick, Elie Dib, Earle F. Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A. Bilen, Raegan O'Lone, Gina N. Grantham, Richard L. Schilsky
Publikováno v:
JCO Precision Oncology.
PURPOSE The TAPUR Study is a phase II basket trial that aims to evaluate activity of approved targeted agents in patients with advanced cancers with potentially actionable genomic variants. Data from a cohort of patients with metastatic castrate-resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6d9e250e0ae7b39ca57bb0a8442c548
https://doi.org/10.1200/po.22.00505
https://doi.org/10.1200/po.22.00505
Autor:
Kristopher Wentzel, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Li Ding, Evan Pisick, Mridula Krishnan, Deepti Behl, Olatunji B. Alese, Carmen J. Calfa, Kathrine A. Cooper, Herbert L. Duvivier, Raghava Reddy Induru, Janet C. Ruzich, Song Zhao, Gina N. Grantham, Abigail Gregory, Susan Halabi, Richard L. Schilsky
Publikováno v:
Cancer Research. 83:CT231-CT231
Background: TAPUR is a phase II basket study evaluating antitumor activity of commercially available targeted agents in pts with advanced cancers with specific genomic alterations. Results in a cohort of pts with solid tumors with PTEN mut treated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f98565e8dd2aa90e2ed497fd20116a38
https://doi.org/10.1158/1538-7445.am2023-ct231
https://doi.org/10.1158/1538-7445.am2023-ct231
Autor:
Martin Sattler, Isa Mambetsariev, Jeremy Fricke, Tingting Tan, Sariah Liu, Nagarajan Vaidehi, Evan Pisick, Tamara Mirzapoiazova, Adam G. Rock, Amartej Merla, Sunil Sharma, Ravi Salgia
Publikováno v:
Journal of Clinical Medicine. 12:1936
The development of EGFR small-molecule inhibitors has provided significant benefit for the affected patient population. Unfortunately, current inhibitors are no curative therapy, and their development has been driven by on-target mutations that inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c2eb0d85815401c683df2c7ac81ba8d
https://doi.org/10.3390/jcm12051936
https://doi.org/10.3390/jcm12051936
Autor:
Sravani Ramisetty, Prakash Kulkarni, Supriyo Bhattacharya, Arin Nam, Sharad S. Singhal, Linlin Guo, Tamara Mirzapoiazova, Bolot Mambetsariev, Sandeep Mittan, Jyoti Malhotra, Evan Pisick, Shanmuga Subbiah, Swapnil Rajurkar, Erminia Massarelli, Ravi Salgia, Atish Mohanty
Publikováno v:
Journal of Clinical Medicine. 12:599
Translational research in medicine, defined as the transfer of knowledge and discovery from the basic sciences to the clinic, is typically achieved through interactions between members across scientific disciplines to overcome the traditional silos w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4edc3ac11612debb4576b4147b765315
https://doi.org/10.3390/jcm12020599
https://doi.org/10.3390/jcm12020599
Autor:
Prakash Kulkarni, Atish Mohanty, Supriyo Bhattacharya, Sharad Singhal, Linlin Guo, Sravani Ramisetty, Tamara Mirzapoiazova, Bolot Mambetsariev, Sandeep Mittan, Jyoti Malhotra, Naveen Gupta, Pauline Kim, Razmig Babikian, Swapnil Rajurkar, Shanmuga Subbiah, Tingting Tan, Danny Nguyen, Amartej Merla, Sudarsan V. Kollimuttathuillam, Tanyanika Phillips, Peter Baik, Bradford Tan, Pankaj Vashi, Sagun Shrestha, Benjamin Leach, Ruchi Garg, Patricia L. Rich, F. Marc Stewart, Evan Pisick, Ravi Salgia
Publikováno v:
Journal of Clinical Medicine. 11:5701
Drug resistance remains one of the major impediments to treating cancer. Although many patients respond well initially, resistance to therapy typically ensues. Several confounding factors appear to contribute to this challenge. Here, we first discuss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd79fef4220ccb4db25ce09d59cb5de
https://doi.org/10.3390/jcm11195701
https://doi.org/10.3390/jcm11195701
Publikováno v:
Journal of Experimental Therapeutics and Oncology. 3:305-318
Small cell lung cancer (SCLC) is an aggressive tumor which metastasizes early. Patients with this disease have a poor prognosis even with immediate treatment. Because of the aggressive nature of this disease, all aspects of this tumor are studied ext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0a8ef50153d05f27cbf76132f415276
https://doi.org/10.1111/j.1533-869x.2003.01103.x
https://doi.org/10.1111/j.1533-869x.2003.01103.x
Publikováno v:
European Journal of Cancer Prevention. 10:77-82
Metastatic carcinoma of unknown primary is a common problem, accounting for up to 10-15% of all solid tumours at presentation. Proper identification of the site of origin has prognostic and therapeutic significance. Prior immunohistochemical methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0ae05148b7af68afce246b5ad43f80
https://doi.org/10.1097/00008469-200102000-00009
https://doi.org/10.1097/00008469-200102000-00009
Autor:
David J. Sugarbaker, James D. Griffin, Ravi Salgia, Lan Bo Chen, William G. Richards, Wen-Che Chen, You-Bin Wang, Evan Pisick, Martin Sattler, Darren S. Ewaniuk, Barrett J. Rollins, Jian-Liang Li, Geoffrey I. Shapiro
Publikováno v:
Oncogene. 18:67-77
Lung cancer can lead to abnormalities of the actin cytoskeleton structure which may be important in transformation. In this study, we have investigated the expression of the cytoskeletal associated protein paxillin in lung cancer. Paxillin is a 68 kD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4ceba786a6d72caacbb958103d0542
https://doi.org/10.1038/sj.onc.1202273
https://doi.org/10.1038/sj.onc.1202273